Chelsea continues to grow as company by building a strong and diverse pipeline in multiple therapeutic categories and varied stages of clinical development. We are dedicated to increasing shareholder value by accelerating the development of lead product candidates and the expansion of our pipeline. We appreciate your continued support and interest in Chelsea Therapeutics. Below, please find the answers to some frequently asked questions:
Chelsea was founded in 2002 in New York under the name Aspen Therapeutics, Inc. In July of 2004, the company was renamed Chelsea Therapeutics, Inc. and established its new corporate headquarters in Charlotte, NC.
In February of 2005, Chelsea completed a reverse merger with Ivory Capital Corporation and began trading on the bulletin board under the ticker IVRC. In July of 2005, the company reincorporated in the state of Delaware under the name Chelsea Therapeutics International, Ltd. and began trading under the ticker CHTP.
In February 2005, we completed a reverse merger with Ivory Capital Corporation and began trading under the ticker IVRC. Following our reincorporation in Delaware, Chelsea began trading under the ticker CHTP.
Corporate Stock Transfer, Inc. is our transfer agent. Corporate Stock Transfer is responsible for maintaining all records of registered stockholders (including change of address and name), canceling or issuing stock certificates, and resolving problems related to lost, destroyed or stolen certificates. If your shares are held in Street name, you will have to contact your broker for these services. You may contact the transfer agent at:
Corporate Stock Transfer, Inc.
3200 Cherry Creek Drive South
Denver, CO 80209